These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The problem of substance abuse in people with schizophrenia. DeLisi LE; Fleischhacker WW Curr Opin Psychiatry; 2015 May; 28(3):199-200. PubMed ID: 25714896 [No Abstract] [Full Text] [Related]
5. Cannabis affects the severity of schizophrenic symptoms: results of a clinical survey. Negrete JC; Knapp WP; Douglas DE; Smith WB Psychol Med; 1986 Aug; 16(3):515-20. PubMed ID: 3489951 [TBL] [Abstract][Full Text] [Related]
6. Adequate antipsychotic treatment normalizes serum nerve growth factor concentrations in schizophrenia with and without cannabis or additional substance abuse. Jockers-Scherübl MC; Rentzsch J; Danker-Hopfe H; Radzei N; Schürer F; Bahri S; Hellweg R Neurosci Lett; 2006 Jun; 400(3):262-6. PubMed ID: 16540246 [TBL] [Abstract][Full Text] [Related]
7. A retrospective study of symptom patterns of cannabis-induced psychosis. Imade AG; Ebie JC Acta Psychiatr Scand; 1991 Feb; 83(2):134-6. PubMed ID: 2017910 [TBL] [Abstract][Full Text] [Related]
8. Medical use of cannabis. Cannabidiol: a new light for schizophrenia? Deiana S Drug Test Anal; 2013 Jan; 5(1):46-51. PubMed ID: 23109356 [TBL] [Abstract][Full Text] [Related]
9. The effects of cannabis use on the clinical condition of schizophrenics. Negrete JC; Knapp WP NIDA Res Monogr; 1986; 67():321-7. PubMed ID: 3092086 [No Abstract] [Full Text] [Related]
10. Dosaging patterns in schizophrenia with depot, oral and combined neuroleptic therapy. Remington GJ; Prendergast P; Bezchlibnyk-Butler KZ Can J Psychiatry; 1993 Apr; 38(3):159-61. PubMed ID: 8098988 [TBL] [Abstract][Full Text] [Related]
12. [Drug abuse experience and neuroleptic prescriptions at the onset of schizophrenia]. Lisoprawski A Sem Hop; 1983 Jun; 59(25):1925-7. PubMed ID: 6136096 [TBL] [Abstract][Full Text] [Related]
16. Cannabis and risk of psychosis. Drewe M; Drewe J; Riecher-Rössler A Swiss Med Wkly; 2004 Nov; 134(45-46):659-63. PubMed ID: 15611887 [TBL] [Abstract][Full Text] [Related]
17. The role of depot neuroleptics in the treatment of schizophrenic patients. Levine J; Schooler NR; Cassano GB Psychol Med; 1979 May; 9(2):383-6. PubMed ID: 38470 [TBL] [Abstract][Full Text] [Related]
18. [Depot neuroleptics in social psychiatric practice]. Pruss U; Rose HK; Zechner A Psychiatr Prax; 1984 Jul; 11(4):101-8. PubMed ID: 6148764 [TBL] [Abstract][Full Text] [Related]
19. Chemotherapy with neuroleptics. Clinical and pharmacokinetic aspects with a particular view to depot preparations. Knudsen P Acta Psychiatr Scand Suppl; 1985; 322():51-75. PubMed ID: 2866666 [TBL] [Abstract][Full Text] [Related]
20. The effect of marijuana use on the risk for schizophrenia. Evins AE; Green AI; Kane JM; Murray RM J Clin Psychiatry; 2012 Nov; 73(11):1463-8. PubMed ID: 23218162 [No Abstract] [Full Text] [Related] [Next] [New Search]